Humacyte adds Scott Coward and Paul Kuznik to board
Coward was appointed to the audit committee and Kuznik to the commercial committee.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Humacyte, Inc. (HUMA) Adds Scott Coward and Paul Kuznik to Board
Humacyte appointed Scott Coward and Paul Kuznik to its Board of Directors, adding commercialization, governance and vascular device expertise.Material DetailsContext by AI AnalystThis is mid-cycle governance/commercial build-out as Humacyte expands Symvess and prepares ATEV AV access launch. Next…